Belongs to

• Center for Hematologic Malignancies

Types of Work

["2023"]

[[["Meeting Abstracts",556],["Journal Articles",364],["Reviews",37],["Research Letters",21],["Book Sections",10],["Guidelines",10],["Correspondences",7],["Editorials",5],["Conference Papers",1]]]

[1011]

Popular keywords

• adult
• aged
• article
• controlled study
• female
• human
• humans
• major clinical study
• male
• multiple myeloma

Recent Works

1. Refining renal response assessment in monoclonal immunoglobulin deposition disease: Challenges, limitations and need for consensus

   Review

   Karam, S.; Pianko, M. J.; Hassoun, H.
   Leukemia (2025)

   Fulltext@MSK | Save
2. Belantamab mafodotin in patients with relapsed/refractory multiple myeloma: A real-world experience

   Journal Article

   Hultcrantz, M.; Derkach, A.; Hassoun, H.; Korde, N.; MacLachlan, K.; Mailankody, S.; Patel, D.; Shah, U. A.; Tan, C. R.; Chung, D. J.; more...
   Blood Neoplasia (2025)

   Fulltext@MSK | Save
3. Impact of daratumumab refractoriness on clinical outcomes following CAR T-cell therapy for relapsed refractory multiple myeloma

   Correspondence

   Sebastian, T.; Rajeeve, S.; Farzana, T.; Firestone, R.; Jurgens, E.; Miller, K.; Costa, B.; Lesokhin, A.; Tan, C.; Shah, G.; more...
   Blood Cancer Journal (2025)

   Fulltext@MSK | Save